What was announced
On 27 August 2024, during the WHO Regional Committee for Africa, 14 African countries — Botswana, Cabo Verde, Chad, Congo, Ethiopia, Gambia, Mauritius, Namibia, Niger, Rwanda, Senegal, Seychelles, South Africa and the United Republic of Tanzania — together with several partners pledged over US$ 45 million to WHO's first-ever Investment Round.
The Investment Round, launched at the World Health Assembly in May 2024, seeks funding that is:
- Flexible — aligned to WHO's Member State-approved strategy rather than earmarked narrowly;
- Predictable — committed at the start of the four-year budget cycle to support planning;
- Resilient — drawn from a broader, more diversified donor base.
Partners signalling support or forthcoming pledges included the Helmsley Charitable Trust, World Diabetes Foundation, Roche, the Kuwait Fund for Arab Economic Development, the Bill & Melinda Gates Foundation, the African Development Bank and the WHO Foundation.
WHO Director-General Dr Tedros Adhanom Ghebreyesus and Regional Director for Africa Dr Matshidiso Moeti both framed sustainable financing as central to outbreak preparedness, disease prevention and health system resilience.
Why travellers may care
This is a financing and governance announcement, not a disease alert. There is no new outbreak, no entry requirement, no vaccination mandate and no travel restriction attached to this news. Severity is informational.
Indirectly, however, WHO's core functions matter to international travellers. WHO coordinates outbreak detection and verification, publishes the International Travel and Health guidance that underpins many national vaccination recommendations, maintains prequalification standards for vaccines and medicines, and supports the International Health Regulations framework through which countries report events of international concern. Funding stability affects the speed and reliability of those outputs.
What to watch
- Further pledging moments through late 2024 and the eventual size of the fully funded four-year budget.
- Any downstream changes to regional surveillance reporting cadence or guidance publication in the WHO African Region.
- Country-level vaccination and entry requirements, which remain set by national authorities — not by WHO funding decisions.
Pharmacist's note
From a pharmaceutical sciences standpoint, the most under-appreciated line item here is WHO prequalification. That programme underwrites the quality, safety and efficacy assessment of vaccines and essential medicines procured by many national programmes and humanitarian agencies. Sustained funding supports the regulatory and laboratory infrastructure that helps keep substandard and falsified products out of supply chains — a recognised risk for travellers purchasing medicines abroad.
Practical takeaways: carry sufficient supply of your own regular medicines in original labelled packaging, keep a copy of your prescription list, and confirm destination-specific import rules for controlled or restricted drugs before departure. For any destination-specific vaccination or prophylaxis questions, consult a travel medicine clinic or your prescriber well ahead of travel — ideally four to six weeks. Nothing in this announcement changes existing recommendations.
Source: World Health Organization, 27 August 2024.